Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Biologists Map the Habits of Cancer Cells
    Health

    Biologists Map the Habits of Cancer Cells

    By Jim Shelton, Yale UniversityApril 8, 2015No Comments4 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Scientists Map the Habits of Cancer Cells
    Researchers have employed advanced technology, blending engineering and medicine, to compile sophisticated data on the complex signaling networks guiding highly invasive cancer cells. This digital field guide provides valuable insights into combating this deadly scourge. Credit: Yale University

    Yale University researchers are mapping the habits of cancer cells, determining which cues cause cancer cells to disperse and metastasize, how these cues are combined with other cues directing the invasion, and which cues hold sway when there are conflicting orders.

    Using advanced technology and an approach that merges engineering and medicine, a Yale University-led team has compiled some of the most sophisticated data yet on the elaborate signaling networks directing highly invasive cancer cells. Think of it as a digital field guide for a deadly scourge.

    “This is a very complex set of interactions and processes,” said Andre Levchenko, a Yale systems biologist and biomedical engineer, and director of the Yale Systems Biology Institute. “The systems biology approach acknowledges that complexity by analyzing how cancer cells migrate together and separately in response to complex cues.”

    In a study published April 8 in the journal Nature Communications, Levchenko and his colleagues describe the intricate ways breast cancer cells respond to chemical cues in the human body. The idea is to determine which cues cause cancer cells to disperse and metastasize, how these cues are combined with other cues directing the invasion, and which cues hold sway when there are conflicting orders.

    Until now, little has been known about how cells decide when and where to turn while traveling through the complex tissues. These cells often encounter contradictory directional cues — begging the questions: Which cues are stronger, and in what situations?

    In this study, researchers focused on several cues. One is a protein called Epidermal Growth Factor (EGF), which acts as a strong, directional guidance signal to individual cancer cells. Another cue mediates a poorly understood phenomenon called “contact inhibition of locomotion” (CIL), in which cells act almost like bumper cars, stopping their forward motion on contact and moving away from each other.

    Levchenko’s team found that when both EGF and CIL signals act upon a breast cancer cell, the cell acts as a tiny computer, making decisions about which cue dominates. If the EGF cue is weak, the cell can turn around if it encounters another cell; if the EGF cue is strong enough, the two cells will travel together. The researchers unraveled the molecular network that allows the cells to follow these cues and make appropriate decisions. In particular, they found the critical role of proteins called ephrins in mediating the CIL cue. These proteins, also found in other cell types, allow breast cancer cells to be repelled from each other, while ignoring other cells, such as fibroblasts. This knowledge allowed the investigators to suppress CIL, so that even weak EGF inputs could lead to coordinated movement of many cells.

    “We have shown that migrating cells prioritize certain cues in the presence of others and thus can switch their migration mode, depending on what they see from the environment,” said first author Benjamin Lin, a postdoctoral associate in biomedical engineering at Yale.

    Understanding the interplay of these signals may allow researchers to devise strategies for interfering with, or redirecting, cancer cells in motion. For example, if a traveling cancer cell received strong, artificial CIL cues so that its movement became less directed and invasive, and more chaotic, could that slow the onset of metastasis?

    Historically, experiments on cancer cell movement have been unable to mimic the dynamic complexity of the human body. Now, using advanced biosensors and other technology, such experiments come much closer to replicating a realistic, biological environment.

    “Scientists have studied quite well how individual cues affect cell migration. But in reality, cells are subject to multiple cues at the same time,” said co-author Takanari Inoue, an associate professor at Johns Hopkins University. “Our work is significant because we clearly demonstrated that cells do integrate multiple pieces of information and that the integration occurs at a place fairly upstream of the signal processing. I think we have been underestimating these cells’ capability to integrate different cues.”

    Additional authors of the paper are Taofei Yin and Yi Wu of the University of Connecticut.

    Reference: “Interplay between chemotaxis and contact inhibition of locomotion determines exploratory cell migration” by Benjamin Lin, Taofei Yin, Yi I. Wu, Takanari Inoue and Andre Levchenko, 8 April 2015, Nature Communications.
    DOI: 10.1038/ncomms7619

     

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Cancer Yale University
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Cavity Shaving Reduces the Risk of a Second Mastectomy

    A Real-Time Blood Test for Cancer Tumors

    Ultrasound Can Detect Cancers Missed by Mammography

    New Drug Combination Delays Breast Cancer Progression

    Yale Researchers Develop Method to Attack Cancer at Its Source

    Neurologists Discover New Method to Fight Glioblastomas

    Yale Researchers Discover New Cancer Cell Vulnerability

    Unique Drug Combinations Show Positive Results in Fighting Late-Stage Melanoma

    New Antibody Drug Boosts the Immune System’s Capacity to Fight Cancer

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Millions Take These IBS Drugs, But a New Study Finds Serious Risks

    Scientists Unlock Hidden Secrets of 2,300-Year-Old Mummies Using Cutting-Edge CT Scanner

    Bread Might Be Making You Gain Weight Even Without Eating More Calories

    Scientists Discover Massive Magma Reservoir Beneath Tuscany

    Europe’s Most Active Volcano Just Got Stranger – Here’s Why Scientists Are Rethinking It

    Alzheimer’s Symptoms May Start Outside the Brain, Study Finds

    Millions Take This Popular Supplement – Scientists Discover a Concerning Link to Heart Failure

    The Universe Is Expanding Too Fast and Scientists Can’t Explain Why

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Doctors Surprised by the Power of a Simple Drug Against Colon Cancer
    • Why Popular Diabetes Drugs Like Ozempic Don’t Work for Everyone: The “Genetic Glitch”
    • Scientists Create Improved Insulin Cells That Reverse Diabetes in Mice
    • Scientists Stunned After Finding Plant Thought Extinct for 60 Years
    • A Common Diabetes Drug May Hold the Key to Stopping HIV From Coming Back
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.